The Immune System and Aging A Review PDF
The Immune System and Aging A Review PDF
The Immune System and Aging A Review PDF
To cite this article: Camil Castelo-Branco & Iris Soveral (2014) The immune system and aging: a
review, Gynecological Endocrinology, 30:1, 16-22, DOI: 10.3109/09513590.2013.852531
IMMUNE SYSTEM
Abstract Keywords
The concept of immunosenescence reflects age-related changes in immune responses, both Aging, immune system, immunosenescence,
cellular and serological, affecting the process of generating specific responses to foreign and innate and adaptive responses
self-antigens. The decline of the immune system with age is reflected in the increased
susceptibility to infectious diseases, poorer response to vaccination, increased prevalence of History
cancer, autoimmune and other chronic diseases. Both innate and adaptive immune responses
are affected by the aging process; however, the adaptive response seems to be more affected Received 8 September 2013
by the age-related changes in the immune system. Additionally, aged individuals tend to Accepted 3 October 2013
present a chronic low-grade inflammatory state that has been implicated in the pathogenesis Published online 12 November 2013
of many age-related diseases (atherosclerosis, Alzheimer’s disease, osteoporosis and diabetes).
However, some individuals arrive to advanced ages without any major health problems,
referred to as healthy aging. The immune system dysfunction seems to be somehow mitigated
in this population, probably due to genetic and environmental factors yet to be described. In
this review, an attempt is made to summarize the current knowledge on how the immune
system is affected by the aging process.
2, IL6
es
P
p t id
Subst α
ance
F
do ACTH 2
1, IL
TN
IL
6
c pe
IL1, IL
s&
s
L
phin
VI P
I
am i
n
D yn s
n
o
hi
er
d or
rp
erf
ti n
Fα
β-en
en
ta
TN
I
os
β-
&
at
m
ns
Immune System
So
ro
rf e
______________
te
In
Circulang Cells
Circulang Molecules
glands
ssues
In order to effectively play their role as sentinels in the entry differences have been observed in the expression of adhesion or
points of the organism, DCs recognize conserved pathogen- chemokine receptors [23,30,31]. Cytokine secretion by NK cells
associated molecular patterns using pattern recognition receptors also seems to be reduced [31] as well as variably diminished
(PRRs) [17], including Toll-like receptors whose function has proliferative response to stimulation with IL-2 [26].
been shown to be compromised in the elderly [18]. Phagocytosis
and migration are also negatively affected by old age via the Neutrophils
phosphoinositide 3-kinase-signaling pathway [19].
The effects of aging on the inflammatory response and T cell Neutrophils are short-lived phagocytic cells circulating in blood
priming by DCs remain unclear [16], although most studies show vessels until they are recruited to site of infection by cytokines
an impaired inflammatory response that might be related to a and chemokines, mainly IL-1 and IL-8. They are the first
decrease in IL-15, tumor necrosis factor (TNF)-a and IFN-a responders to microbial and parasitic infections and act by three
expression in response to viral infections and vaccines [19–21]. main mechanisms: phagocytosis (requiring opsonization), gener-
ation of reactive oxygen species and degranulation (releasing
Natural killer cells enzymes and antimicrobial peptides) and neutrophil extracellular
traps [32,33].
Natural killer cells (NK cells) play an important role within the Most studies suggest that age does not affect the number of
innate immune response. They recognize and eliminate cells neutrophils, but it seems that their ability to increase their life
lacking MHC class I molecules without previous sensitization or span in response to survival signals (IFN-1, GM-CSF) produced
activation by other cells; they play a role in maintaining innate at the site of infection is decreased [34,35]. Chemotaxis results in
and adaptive immune responses by secreting a variety of adhesion to endothelial cells and migration through them into the
cytokines [22,23]. These two main mechanisms, cell cytotoxicity affected tissue. The mechanisms of adhesion and migration seem
and cytokine secretion, are carried out by two main subpopula- to remain unaffected [36,37], but it remains unclear whether
tions: CD56dimCD16þ NK cells, which are truly cytotoxic cells chemotaxis is affected by age [33,36–38]. In regards to phago-
with low cytokine production and CD56brightCD16- NK cells, cytosis, most authors agree that the phagocytic function and the
which are less differentiated cells whose main response upon intracellular respiratory burst necessary to kill bacteria are
activation is cytokine and chemokine production [24]. reduced in the elderly [36,39–43]. The defect in phagocytosis of
It is widely accepted that there is an increase in the number of opsonized bacteria and superoxide generation seems to depend on
NK cells in the elderly [22,23,25]. This increase seems to be the a reduced expression of CD16 (Fc receptor) [41]. How age affects
result of an accumulation of mature cells in the organism and as the generation of neutrophil extracellular traps remains to be
such, results in an increase in the CD56dim population [26]. clarified [44].
Nonetheless, this increase in NK cells is not associated with an
increase in global cytotoxicity. It can be that this increase in NK
Macrophages
cells constitutes a compensation mechanism of the reduced per-
cell cytotoxicity that seems to be secondary to a decreased Macrophages are tissue resident phagocytes, derived from
perforin secretion [27]. circulating monocytes and like the DCs possess abundant Toll-
In murine models NK cells migration has been shown to be like receptors being, therefore, capable of recognizing pathogens
affected [28,29], although in human studies no age-related with conserved pathogen-associated molecular patterns and
DOI: 10.3109/09513590.2013.852531 Immunosenescence 19
initiating the inflammatory response. Tissue-macrophages play an immunoglobulin production and these present lower affinities
important role in the recruitment of neutrophils by synthetizing toward the antigens [66]. Although fewer plasma cells are
pro-inflammatory cytokines and chemokines, such as TNF-a, generated, their individual antibody secreting function seems to
IL-1, IL-6 and IL-8 [32]. They are also capable of processing and be intact [66] and the somatic hypermutation apparatus seems to
presenting antigens to T cells and participate in the regulation of be preserved [67].
the adaptive immune response [38]. Additionally, when a primary antibody response is needed in
In older people, macrophages present a reduced production of the presence of new antigens, a delayed response with lower levels
cytokines such as TNF-a and IL-6 in response to TLR1/2 but not of high-affinity antibodies is observed in the elderly that is
other TLR that might be responsible for a less potent recruitment compensated later by clonal expansion, which can be explained
of neutrophils and other cells [45]. Additionally, TLR-induced by the decrease in naı̈ve B cell pool [68]. Globally, the
expression of B7 (B7 – CD80 and CD86 – unite to either CD28 or circulating immunoglobulins become dominated by those with
CD152 in the T cell producing a co-stimulatory signal) is somatic mutations compatible with their generation primarily
decreased in the elderly [46]. Also, they show an altered by memory B cells and an increase in auto-antibodies is
expression of MHC class II molecules (with decreased observed [69].
HLA-DR/DQ and increased HLA-DQ), whose significance Accompanying the decrease in high-affinity antibodies, the
remains unclear but can contribute to a poorer T cell response ability of the humoral response to produce antibodies capable of
[47]. Studies on mouse models have shown that macrophages opsonizing bacteria for neutralization by phagocytosis is also
from aged individuals express less MHC class [48] after impaired in older people [70].
stimulation with IFN-gamma II, show impaired phagocytosis It would seem that three major impairments affect B cells with
[49,50] and present a decreased ability to produce reactive oxygen aging: a decrease in the number of naı̈ve B cells and therefore an
species [51], although these findings are yet to be replicated impaired capacity for response to new antigens; a reduced clonal
in humans. expansion capability of memory B cells that correlates with a
lower level of circulating antibodies after contact with a
previously known antigen and functionally impaired antibodies
The adaptive response
with lower affinities and decreased opsonizing abilities.
Lymphoid progenitors
Hematopoietic stem cells (HSCs) are found mainly in the bone T cells
marrow and are responsible for the continuous supply of both
T cells are characterized by the presence of T cell receptors
myeloid and lymphoid progenitors necessary for an adequate
(TCRs) and can be categorized in two main subsets by the cell
immune response.
surface expression of either CD4 or CD8. CD4þ cells, which
With age, the proliferative capacity of the HSC diminishes [52]
recognize antigens in the context of Class II major histocompati-
and a shift is seen toward the production of myeloid progenitors
bility complex (MHC), are mainly regulatory cells, whereas
[53,54]. Several mechanisms have been proposed, including the
CD8þ cells are mainly cytotoxic cells that recognize antigen
shortening of telomeres [55], epigenetic changes secondary to a
presented within Class I MHC molecules. Both functions are of
decreased DNA methylation in the HSC that could be responsible
vital importance in the adaptive and innate immune responses.
for the shift toward the myeloid series (as myeloid progenitors
The absolute number of T cells decrease with age and, as in
present lower DNA methylation than the lymphoid progenitors)
B cells, this decrease affects more importantly the naı̈ve subset
[56–58] and changes in the HSC niche including the cytokine
[71]. T cell differentiation takes place in the thymus and results in
milieu [59].
the production of CD4þ or CD8þ naı̈ve cells, which are then
exported to the periphery [72]. During maturation, T cells
B cells
rearrange TCR genes resulting in the production of DNA
B cells’ main function is the production of specific antibodies in fragments known as T cell receptor excision circles (TRECs)
response to a specific antigen and this function is crucial to the that have been used as an indirect measure of thymopoietic
effective response against bacterial infections and vaccination potential [73,74]
[60]. High-affinity-specific antibodies are generated by somatic Thymic involution has been well established in the literature
hypermutation of immunoglobulin genes in the germinal center of and is considered to be the main mechanism by which the pool of
secondary lymphoid tissue after which professional antibody naı̈ve T cells declines with age [72,75]. This decline affects
secreting plasma cells migrate to the blood stream [61]. CD4þ and CD8þ cells differently with a greater contraction in
In line with the reduced ability of HSCs to generate new B CD8þ numbers and a better preserved population of naı̈ve CD4þ
lymphocytes, the total number of B cells seems to diminish with cells [74,76–78]. Accompanying the numeric defect in naı̈ve
age [62,63]. Additionally, a decrease in diversity of the B cell T cells, functional defects (especially in the CD8 subset) have
repertoire is seen in older people, characterized by a decrease in been described such as antigen-independent activation and
naı̈ve B cells (CD27; with few somatic mutations in immuno- proliferation rates. These cells that maintain a naı̈ve phenotype
globulin genes) and an increase in memory B cells (CD27þ; with are less capable of producing an adequate response when
multiple somatic mutations) [60,62,64]. These memory B cells presented with a new antigen [77].
present an increased resistance to apoptosis. Furthermore, some Activation of both naı̈ve and memory T cells is a complex
studies describe a subtype of B cell – called aging-associated process that requires the intervention of co-stimulatory molecules
B-cell – that accumulates with age (possibly displacing naı̈ve after the binding of TCR to MHC molecules [72]. CD28 is an
B cells) [58] that respond to innate but not adaptive immunity important co-stimulatory molecule present in T cells and the
stimuli [65], although more studies are needed to clarify their role binding of CD28 to its co-receptor (B7, present in antigen
in humans. presenting cells) results in potent activation stimuli for T cells
Consistent with the change in B cell subsets, antibody [79]. CD28 presence in T cells decreases with cell differentiation
production is also affected by age. In response to vaccines, from naive to central memory to effector memory cells as a result
older people present a slower response, a reduced clonal of persistent antigenic stimulation and repeated proliferation
expansion of plasma cells that correlates with a decrease in cycles [80]. The activation of T cells via TCR-CD28 does not
20 C. Castelo-Branco & I. Soveral Gynecol Endocrinol, 2014; 30(1): 16–22
seem to be impaired in old people [81]. However, with age, CD28 Telomere shortening
Thymus
expression decreases in both CD4þ and CD8þ T cells [82,83], Oxidave stress
involuon
consistent with a decreased naive cell pool and the accumulation
of highly differentiated T cells. CD27, a TNF receptor, suffers the Immunosenescence
same changes as CD28 with decreased expression as T cells
differentiate [71,72,77]. As such, CD27/CD28 T cells repre- Hormonal Decreased
sent highly differentiated effector T cells that accumulate in old Chronic infecons T cell funcon
changes
Autoimmune diseases
age. They have limited proliferative capability but as they are
apoptosis resistant, an accumulation is seen with age, mainly in
CD8þ cells [84]. However, the proliferative capability of these Increased inflammatory acvity
CD27/CD28 cells seems to be better preserved in the CD4þ
population, because these cells maintain a certain antigen-induced
telomerase activity [85].
Type 2 Diabetes
Another change seen in differentiated T cells in old age is the Demena Atherosclerosis
Osteoporosis
acquisition, mainly in CD8þ cells but also in CD4þ, of NK
markers, such as CD56 [86–88]. The presence of the NK cell Figure 3. Inflamm-aging consequences.
markers is associated with an increased presence of cytotoxic
molecules [89] and allows CD28 T cells to be activated
independently of TCR and maintaining their cytotoxic capabil- Table 2. Shift in cytokines with age.
ity although their proliferative capability remains diminished
[89,90]. " IL-1, IL-6, TNF-a
In conclusion, T cells are deeply affected with aging but CD8þ " Cytokine production imbalance
cells seem to be affected to greater extent, which suggests that # IL-2
CD4þ cells are subject to stricter homeostatic mechanisms given " IL-8 (which can recruit macrophages and may lead to lung
inflammation dysfunctional IL-8)
the importance of these cells in the maintenance of the immune # Interferon-g
system function [91].
Altered cytokine responsiveness of NK cells
The degree of T cell impairment is also variable among " IL-10 and IL-12 up-regulated by antigen processing cells
individuals and a T cell immune risk profile has been established,
characterized by an inverted CD4/CD8 ratio, an accumulation of
CD8þ/CD28 cells and CMV infection [88,92]. This immune
Table 3. Changes affecting the innate immune system with age.
profile is associated with increased mortality and age-related
diseases [92]. Impairment of anatomical barriers
# Number of Langerhan cells
Inflamm-aging # Pathogen recognition by DCs
" Numbers of less functional NK cells
Inflamm-aging refers to a chronic state of low-grade inflamma- # Neutrophil survival in response to stimuli
tion that accompanies the aging process characterized by # Neutrophil phagocytic function and respiratory burst generation
increased levels of circulating cytokines and pro-inflammatory # Cytokine production by macrophages
markers [93]. It is associated with many age-related diseases, such # T cell activation by macrophages
as atherosclerosis, Alzheimer’s disease, osteoporosis and diabetes
(Figure 3) [93]. Among such pro-inflammatory cytokines TNF-a
[94], IL1 [95] and IL6 [96] seem to play a major role. Table 2 Table 4. Changes affecting the adaptive immune system with age.
records the shift in cytokines with aging. However, in healthy
aging these pro-inflammatory states seem to be somewhat # Lymphoid progenitors production
# Number of B cells, specially naı̈ve cells
inhibited by anti-inflammatory cytokines such as IL-10 [97]. " Apoptosis resistance of memory B cells
# Antibody production, with lower affinities and decreased opsonizing
Conclusions abilities
Immunosenescence is a complex process that affects the Delayed antibody response to new antigens
# Number of T cells, specially naı̈ve and CD8þ cells
immune system on the whole (summarized in Tables 3 and 4)
" Antigen-independent activation and proliferation of naı̈ve T cells
and reflects upon the organism’s ability of adequately respond- # CD28þ T cells as a result of accumulation of mature cells
ing to pathogens. There is no single impairment to be blamed; " Apoptosis resistance of memory T cells
instead it is a multilevel dysfunction that affects individuals to a Acquisition of NK cell markers by T cells
different extent. As a result, elderly people present increased # Cytotoxic capability of CD8þ cells
susceptibility to infections [98], decreased responses to vac-
cination [66] and poorer responses to known and new
antigens. Additionally, aged individuals tend to present a chronic Declaration of interest
low-grade inflammatory state that has been implicated in the The authors report no conflicts of interest. The authors alone are
pathogenesis of many age-related diseases (atherosclerosis, responsible for the content and writing of this article.
Alzheimer’s disease, osteoporosis, diabetes) [95–97]. Also, the
increased prevalence of cancer has been associated with an age-
related impairment of the immune surveillance function [22]. References
However, some individuals arrive to advanced ages without any
1. Derhovanessian E, Solana R, Larbi A, Paweler G. Immunity, ageing
major health problems, referred to as healthy aging. The immune and cancer. Immun Ageing 2008;5:11.
system dysfunction seems to be somehow mitigated in this 2. Tonet AC, Nóbrega OT. Immunosenescence: the association
population, probably due to genetic and environmental factors yet between leukocytes, cytokines and chronic diseases. Rev Brás
to be described. Geriatr Gerontol 2008;11:259–73.
DOI: 10.3109/09513590.2013.852531 Immunosenescence 21
3. Krabbe KS, Pedersen M, Brunsgaard H. Inflammatory mediators in 30. Hayhoe RP, Henson SM, Akbar AN, Palmer DB. Variation of human
the elderly. Exp Gerontol 2004;39:687–99. natural killer cell phenotypes with age: identification of a unique
4. Pawelec G. Immunosenescence: impact in the young as well as the KLRG1-negative subset. Hum Immunol 2010;71:676–81.
old? Mech Ageing Dev 1999;108:1. 31. Mariani E, Meneghetti A, Neri S, et al. Chemokine production by
5. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role natural killer cells from nonagenarians. Eur J Immunol 2002;32:
and measurement in influenza vaccine response among the elderly. 1524–9.
Vaccine 2007;25:3066. 32. Borregaard N. Neutrophils, from marrow to microbes. Immunity
6. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: 2010;33:657–70.
the prevailing of innate immunity, the failing of clonotypic 33. Panda A, Arjona A, Sapey E, et al. Human innate immunosenes-
immunity, and the filling of immunological space. Vaccine 2000; cence: causes and consequences for immunity in old age. Trends
18: 1717. Immunol 2009;30:325–33.
7. Fenske NA, Conard CB. Aging skin. Am Fam Physician. 1988;37: 34. Chatta GS, Andrews RG, Rodger E, et al. Hematopoietic progenitors
219–30. and aging: alterations in granulocytic precursors and responsiveness
8. Kurban RS, Bhawan J. Histologic changes in skin associated with to recombinant human G-CSF, GM-CSF, and IL-3. J Gerontol 1993;
aging. J Dermatol Surg Oncol 1990;16:908–14. 48:M207.
9. Kottner J, Lichterfeld A, Blume-Peytavi U. Maintaining Skin 35. Fortin CF, Larbi A, Dupuis G, et al. GM-CSF activates the Jak/
Integrity in the Aged: A Systematic Review. Br J Dermatol STAT pathway to rescue polymorphonuclear neutrophils from
2013;169:528–42. spontaneous apoptosis in young but not elderly individuals.
10. Grewe M. Chronological ageing and photoageing of dendritic cells. Biogerontology. 2007;8:173–87.
Clin Exp Dermatol 2001;26:608–12. 36. Wenisch C, Patruta S, Daxböck F, et al. Effect of age on human
11. Jorissen M, Willems T, Van der Schueren B. Nasal ciliary beat neutrophil function. J Leukoc Biol 2000;67:40–5.
frequency is age independent. Laryngoscope 1998;108:1042–7. 37. Fortin CF, Larbi A, Lesur O, et al. Impairment of SHP-1
12. Kim SW, Mo JH, Kim JW, et al. Change of nasal function with aging downregulation in the lipid rafts of human neutrophils under GM-
in Korean. Acta Otolaryngol Suppl 2007;(558):90–4. CSF stimulation contributes to their age-related, altered functions.
13. Jafarzadeh A, Sadeghi M, Karam GA, Vazirinejad R. Salivary J Leukoc Biol 2006;79:1061–72.
IgA and IgE levels in healthy subjects: relation to age and gender. 38. Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of
Braz Oral Res 2010;24:21–7. the immune system. Transpl Int 2009;22:1041–50.
14. Agrawal A, Gupta S. Impact of aging on dendritic cell functions in 39. Emanuelli G, Lanzio M, Anfossi T, et al. Influence of age on
humans. Ageing Res Rev 2011;10:336–45. polymorphonuclear leukocytes in vitro: phagocytic activity in
15. Jing Y, Shaheen E, Drake RR, et al. Aging is associated with a healthy human subjects. Gerontology 1986;32:308.
numerical and functional decline in plasmacytoid dendritic cells, 40. Butcher SK, Chahal H, Nayak L, et al. Senescence in innate immune
whereas myeloid dendritic cells are relatively unaltered in human responses: reduced neutrophil phagocytic capacity and CD16
peripheral blood. Human Immunol 2009;70:777–84. expression in elderly humans. J Leukoc Biol 2001;70:881.
16. Wong C, Goldstein DR. Impact of aging on antigen presentation cell 41. Fulop Jr T, Foris G, Worum I, Leovey A. Age-dependent alterations
function of dendritic cells. Curr Opin Immunol 2013;25:535–41. of Fc gamma receptor-mediated effector functions of human
17. Kumar H, Kawai T, Akira S. Pathogen recognition in the innate polymorphonuclear leucocytes. Clin Exp Immunol 1985;61:425.
immune response. Biochem J 2009;420:1–16. 42. Simell B, Vuorela A, Ekström N, et al. Aging reduces the
18. Panda A, Qian F, Mohanty S, et al. Age-associated decrease in TLR functionality of anti-pneumococcal antibodies and the killing of
function in primary human dendritic cells predicts influenza vaccine Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine
response. J Immunol 2010;184:2518–27. 2011;29:1929–34.
19. Agrawal A, Agrawal S, Cao JN, et al. Altered innate immune 43. Fortin CF, McDonald PP, Lesur O, Fulop Jr T. Aging and
functioning of dendritic cells in elderly humans: a role of neutrophils: there is still much to do. Rejuvenation Res 2008;11:
phosphoinositide 3-kinase-signaling pathway. J Immunol 2007; 873–82.
178:6912–22. 44. Solana R, Tarazona R, Gayoso I, et al. Innate immunosenescence:
20. Moretto MM, Lawlor EM, Khan IA. Aging mice exhibit a functional effect of aging on cells and receptors of the innate immune system in
defect in mucosal dendritic cell response against an intracellular humans. Semin Immunol 2012;24:331–41.
pathogen. J Immunol 2008;181:7977–84. 45. van Duin D, Mohanty S, Thomas V, et al. Age-associated defect in
21. Stout-Delgado HW, Yang X, Walker WE, et al. Aging impairs IFN human TLR-1/2 function. J Immunol 2007;178:970–5.
regulatory factor 7 up-regulation in plasmacytoid dendritic cells 46. van Duin D, Allore HG, Mohanty S, et al. Prevaccine determination
during TLR9 activation. J Immunol 2008;181:6747–56. of the expression of costimulatory B7 molecules in activated
22. Camous X, Pera A, Solana R, Larbi A. NK cells in healthy monocytes predicts influenza vaccine responses in young and older
aging and age-associated diseases. J Biomed Biotechnol 2012; adults. J Infect Dis 2007;195:1590–7.
2012:195956. 47. Villanueva JL, Solana R, Alonso MC, Peña J. Changes in the
23. Hazeldine J, Lord JM. The impact of ageing on natural killer cell expression of HLA-class II antigens on peripheral blood monocytes
function and potential consequences for health in older adults. from aged humans. Dis Markers 1990;8:85–91.
Ageing Res Rev 2013. [Epub ahead of print]. 48. Herrero C, Sebastián C, Marqués L, et al. Immunosenescence of
24. Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of macrophages: reduced MHC class II gene expression. Exp Gerontol
human NK-cell cytokine and chemokine production by target cell 2002;37:389.
recognition. Blood 2010;115:2167–76. 49. Izgüt-Uysal VN, Ozkaya YG, Ozdemir S, et al. Effect of L-arginine
25. Facchini A, Mariani E, Mariani AR, et al. Increased number of on age-related changes in macrophage phagocytic activity. Immunol
circulating Leu 11þ (CD 16) large granular lymphocytes and Invest 2004;33:287–93.
decreased NK activity during human ageing. Clin Exp Immunol 50. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations
1987;68:340–7. in the inflammatory response to dermal injury. J Invest Dermatol
26. Borrego F, Alonso MC, Galiani MD, et al. NK phenotypic markers 2001;117:1027–35.
and IL2 response in NK cells from elderly people. Experimental 51. Davila DR, Edwards III CK, Arkins S, et al. Interferon-g-induced
Gerontology 1999;34:253–65. priming for secretion of superoxide anion and tumor-necrosis
27. Hazeldine J, Hampson P, Lord JM. Reduced release and binding of factor-a declines in macrophages from aged rats. FASEB J 1990;
perforin at the immunological synapse underlies the age-related 4:2906–11.
decline in natural killer cell cytotoxicity. Aging Cell 2012;11:751–9. 52. Lansdorp PM, Dragowska W, Thomas TE, et al. Age-related decline
28. Beli E, Clinthorne JF, Duriancik DM, et al. Natural killer cell in proliferative potential of purified stem cell candidates. Blood
function is altered during the primary response of aged mice to Cells 1994;20:376.
influenza infection. Mech Ageing Dev 2011;132:503–10. 53. Beerman I, Bhattacharya D, Zandi S, et al. Functionally distinct
29. Fang M, Roscoe F, Sigal LJ. Age-dependent susceptibility to a viral hematopoietic stem cells modulate hematopoietic lineage potential
disease due to decreased natural killer cell numbers and trafficking. during aging by a mechanism of clonal expansion. Proc Natl Acad
J Exp Med 2010;207:2369–81. Sci USA 2010;107:5465–70.
22 C. Castelo-Branco & I. Soveral Gynecol Endocrinol, 2014; 30(1): 16–22
54. Cho RH, Sieburg HB, Muller-Sieburg CE. A new mechanism for the 77. Ferrando-Martı́nez S, Ruiz-Mateos E, Hernández A, et al.
aging of hematopoietic stem cells: aging changes the clonal Age-related deregulation of naive T cell homeostasis in elderly
composition of the stem cell compartment but not individual stem humans. Age 2011;33:197–207.
cells. Blood 2008;111:5553–61. 78. Fagnoni FF, Vescovini R, Passeri G, et al. Shortage of circulating
55. Vaziri H, Dragowska W, Allsopp RC, et al. Evidence for a mitotic naive CD8(þ) T cells provides new insights on immunodeficiency in
clock in human hematopoietic stem cells: loss of telomeric DNA aging. Blood 2000;95:2860–8.
with age. Proc Natl Acad Sci USA 1994;91:9857. 79. Finney HM, Akbar AN, Lawson AD. Activation of resting human
56. Ji H, Ehrlich LI, Seita J, et al. Comprehensive methylome map of primary T cells with chimeric receptors: costimulation from CD28,
lineage commitment from haematopoietic progenitors. Nature 2010; inducible costimulator, CD134, and CD137 in series with signals
467:338–42. from the TCR zeta chain. J Immunol 2004;172:104–13.
57. Chambers SM, Shaw CA, Gatza C, et al. Aging hematopoietic stem 80. Vallejo AN. CD28 extinction in human T cells: altered functions and
cells decline in function and exhibit epigenetic dysregulation. PLoS the program of T-cell senescence. Immunol Rev 2005;205:158–69.
Biol 2007;5:e201. 81. Sansoni P, Fagnoni F, Vescovini R, et al. T lymphocyte proliferative
58. Kogut I, Scholz JL, Cancro MP, Cambier JC. B cell maintenance and capability to defined stimuli and costimulatory CD28 pathway is not
function in aging. Semin Immunol 2012;24:342–9. impaired in healthy centenarians. Mech. Ageing Dev 1997;96:
59. Challen GA, Boles NC, Chambers SM, Goodell MA. Distinct 127–36.
hematopoietic stem cell subtypes are differentially regulated by 82. Weyand CM, Brandes JC, Schmidt D, et al. Functional properties of
TGF-beta1. Cell Stem Cell 2010;6:265–78. CD4þ CD28 T cells in the aging immune system. Mech Ageing
60. Gibson KL, Wu YC, Barnett Y, et al. B-cell diversity decreases in Dev 1998;102:131–47.
old age and is correlated with poor health status. Aging Cell 2009;8: 83. Nociari MM, Telford W, Russo C. Postthymic development of
18–25. CD28-CD8þ T cell subset: age-associated expansion and shift from
61. MacLennan IC. Germinal centers. Annu Rev Immunol 1994;12: memory to naive phenotype. J Immunol 1999;162:3327–35.
117–39. 84. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ. Clonality and
62. Chong Y, Ikematsu H, Yamaji K, et al. CD27(þ) (memory) B cell longevity of CD4þCD28null T cells are associated with defects in
decrease and apoptosis-resistant CD27() (naive) B cell increase in apoptotic pathways. J Immunol 2000;165:6301–7.
aged humans: implications for age-related peripheral B cell devel- 85. Valenzuela HF, Effros RB. Divergent telomerase and CD28
opmental disturbances. Int Immunol 2005;17:383–90. expression patterns in human CD4 and CD8 T cells following
63. Ademokun A, Wu YC, Dunn-Walters D. The ageing B cell repeated encounters with the same antigenic stimulus. Clin Immunol
population: composition and function. Biogerontology. 2010;11: 2002;105:117–25.
125–37. 86. Abedin S, Michel JJ, Lemster B, Vallejo AN. Diversity of NKR
64. Johnson SA, Rozzo SJ, Cambier JC. Aging-dependent exclusion of expression in aging T cells and in T cells of the aged: the new
antigen-inexperienced cells from the peripheral B cell repertoire. frontier into the exploration of protective immunity in the elderly.
Exp Gerontol 2005;40:537–48.
J Immunol 2002;168:5014–5023.
87. Fagnoni FF, Vescovini R, Mazzola M, et al. Expansion of cytotoxic
65. Rubtsov AV, Rubtsova K, Fischer A, et al. Toll-like receptor 7
CD8þ CD28_ T cells in healthy ageing people, including centen-
(TLR7)-driven accumulation of a novel CD11cþ B-cell population is
arians. Immunology 1996;88:501–7.
important for the development of autoimmunity. Blood 2011;118:
88. Moro-Garcı́a MA, Alonso-Arias R, López-Larrea C. When aging
1305–15.
reaches CD4þ T-cells: phenotypic and functional changes. Front
66. Sasaki S, Sullivan M, Narvaez CF, et al. Limited efficacy of
Immunol 2013;4:107.
inactivated influenza vaccine in elderly individuals is associated 89. Brown DM, Lee S, Garcia-Hernandez ML, Swain SL.
with decreased production of vaccine-specific antibodies. J Clin Multifunctional CD4 cells expressing gamma interferon and perforin
Invest 2011;121:3109–19. mediate protection against lethal influenza virus infection. J Virol
67. Dunn-Walters DK, Banerjee M, Mehr R. Effects of age on antibody 2012;86:6792–803.
affinity maturation. Biochem Soc Trans 2003;31:447–8. 90. Tarazona R, DelaRosa O, Alonso C, et al. Increased expression of
68. Roukens AH, Soonawala D, Joosten SA, et al. Elderly subjects have NK cell markers on T lymphocytes in aging and chronic activation
a delayed antibody response and prolonged viraemia following of the immune system reflects the accumulation of effector/
yellow fever vaccination: a prospective controlled cohort study. senescent T cells. Mech Ageing Dev 2000;121:77–88.
PLoS One 2011;6:e27753. 91. Sansoni P, Vescovini R, Fagnoni F, et al. The immune system in
69. Nagele EP, Han M, Acharya NK, et al. Natural IgG autoantibodies extreme longevity. Exp Gerontol 2008;43:61–5.
are abundant and ubiquitous in human sera, and their number is 92. Olsson J, Wikby A, Johansson B, et al. Age-related change in
influenced by age, gender, and disease. PLoS One 2013;8:e60726. peripheral blood T-lymphocyte subpopulations and cytomegalovirus
70. Schenkein JG, Park S, Nahm MH. Pneumococcal vaccination in infection in the very old: the Swedish longitudinal OCTO immune
older adults induces antibodies with low opsonic capacity and study. Mech Ageing Dev 2000;121:187–201.
reduced antibody potency. Vaccine 2008;26:5521–6. 93. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An
71. Koch S, Larbi A, Derhovanessian E, et al. Multiparameter flow evolutionary perspective on immunosenescence. Ann NY Acad Sci
cytometric analysis of CD4 and CD8 T cell subsets in young and old 2000;908:244–54.
people. Immun Ageing 2008;5:6. 94. Bruunsgaard H, Andersen-Ranberg K, Jeune B, et al. A high plasma
72. Moro-Garcı́a MA, Alonso-Arias R, López-Larrea C. Molecular concentration of TNF-alpha is associated with dementia in centen-
mechanisms involved in the aging of the T-cell immune response. arians. J Gerontol 1999;54A:M357–64.
Curr Genomics 2012;13:589–602. 95. Griffin WS. Inflammation and neurodegenerative diseases. Am J
73. Hazenberg MD, Verschuren MC, Hamann D, et al. T cell receptor Clin Nutr 2006;83:470S–4S.
excision circles as markers for recent thymic emigrants: basic 96. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein,
aspects, technical approach, and guidelines for interpretation. J Mol interleukin 6, and risk of developing type 2 diabetes mellitus.
Med 2001;79:631–40. JAMA 200;286:327–34.
74. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic 97. Lio D, Candore G, Crivello A, et al. Opposite effects of interleukin
function with age and during the treatment of HIV infection. Nature 10 common gene polymorphisms in cardiovascular diseases and in
1998;396:690–5. successful ageing: genetic background of male centenarians is
75. Ferrando-Martı́nez S. Thymopoiesis in elderly human is associated protective against coronary heart disease. J Med Genet 2004;41:
with systemic inflammatoruy status. Age 2009;31:87–97. 790–4.
76. Gupta S, Bi R, Su K, et al. Characterization of naı̈ve, memory and 98. Gavazzi G, Herrmann F, Krause KH. Aging and infectious diseases
effector CD8þ T cells: effect of age. Exp Gerontol 2004;39:545–50. in the developing world. Clin Infect Dis 2004;39:83–91.